Clinical Trial Results:
A multicentre, multinational, randomised, double-blind, parallel-group study comparing ACR16 45mg once-daily or twice-daily versus placebo for the symptomatic treatment of Huntington’s Disease
Summary
|
|
EudraCT number |
2007-004988-22 |
Trial protocol |
GB DE BE FR ES PT AT IT |
Global completion date |
14 Jun 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Jan 2023
|
First version publication date |
28 Jan 2023
|
Other versions |
|
Summary report(s) |
ACR16C008 CSR Synopsis 10Jan2023_Redacted.pdf |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.